ID, Substance Abuse and Recovery
|
|
- Lorena Sparks
- 6 years ago
- Views:
Transcription
1 ID, Substance Abuse and Recovery The South Carolina Primary Healthcare Association Clinical Network Retreat, Myrtle Beach, SC 06/12/2011 Ralph Rynes, PhD, NCAC II LRADAC USC School of Medicine and the SC HIV/AIDS Clinical Training Center (803)
2 None Financial Disclosures
3 Ralph Rynes, PhD Copyright 2011 Ralph Rynes, PhD All Rights Reserved Reproduction or use of this presentation, in whole or in part, without the express written consent of the author is prohibited
4 True or False? Addiction is an acute condition that can be effectively treated with detox Treatment should produce a long lasting reduction in symptoms following termination of Tx Relapse should be considered a failure of Tx Relapse can occur before an addict picks up a drink or drug Worrying about others instead of self can trigger relapse Being addicted to prescription drugs is different from being addicted to street drugs Tx doesn t work
5 The Truth Addiction is a brain disorder THERE IS NO MAGIC PILL / MAGIC BULLET Medications are not always appropriate Specific meds. should be avoided (i.e. benzos) If used, medications must be accompanied by behavioral interventions Interventions must be pt. specific and tailored to that pt. s stage of recovery Addiction is a chronic condition that requires ongoing assessment and Tx TREATMENT WORKS
6 General ID Risk Factors that Happen to Have a High Correlation with Substance Abuse Hx of ID Poor nutrition High stress & y disorders CrJ Involvement High risk sex practices Overlapping social environments Consider possibility of PTSD
7 Time Often substance abusers fail to recognize symptoms of disease and seek Tx only when they become acutely ill or emergent, thus prolonging the time they spread infectious conditions to others HIV or Hep C may be asymptomatic for many years (HIV-10 years), (Hep C- 20 years) so many partners may be infected Processing time (denial, etc.)
8 Most Commonly Abused Drugs in the U.S. Alcohol (combined with cocaine, marijuana, or heroin) Cocaine Marijuana Heroin/morphine Alprazolam (Xanax) Hydrocodone (Vicodin, Lorcet, Lortab) Unspecified benzodiazepines Oxycodone (OxyContin, Percocet, Percodan, Tylox)
9 Most Commonly Abused Drugs in the U.S. con t. Methadone Clonazepam (Klonopin) Propoxyphene Darvocet N, Darvon ) Amphetamine (Dexedrine) Lorazepam (Ativan) Carisoprodol (Soma) Diazepam (Valium) Methamphetamine (Desoxyn, speed, Tina) Trazodone (Desyrel)
10
11 Let s get specific: Crack: May have multiple sex partners while using and may have indiscriminate sex to get drugs or the money to buy them Crack users nationwide have unusually high rates of syphilis infection (often heterosexual men who seek Tx for secondary syphilis and then test + for HIV) Smoking crack degrades oral mucosa, leading to open ulcers. In vitro studies indicate increased HIV replication in 1 the presence of cocaine In recovery, anhedonia impacts rewards of appetite directed behaviors (sleeping, eating) and function directed behaviors (work, responsibilities) 1. Tashkin Journal of Neuroimmunology 2003
12 How Cocaine Works The neurotransmitter dopamine transmits brain signals by flowing from one neuron across the synapse and attaching to a receptor on another neuron. Normally, dopamine then is recycled back into the transmitting neuron by a transporter molecule on the surface of the neuron. But if cocaine is present, the drug attaches to the transporter and blocks the normal recycling of dopamine, causing an increase of synaptic dopamine levels that leads to euphoria. Source: Swan, N. NIDA Notes Vol. 13 #2; 1998
13 Cocaine & Sex Functional MRI showing activation of the same brain sites in cocaine addicts watching a cocainecraving-inducing film (left) and non-drugusing subjects watching a film depicting explicit sexual scenes (right). This suggests that cue-induced cocaine craving and sexual excitement are associated with the same brain sites. Source: Zickler, NIDA Notes Vol 16 #2, 2001
14 Limbic Activation on Cue PET scan shows that limbic regions in the brains of intreatment cocaine users are activated by watching cocaine-related videos. Watching videos of nature scenes does not result in activation of these regions. This suggests that cueinduced craving for cocaine reflects activity in specific regions of the brain. Source: Zickler, NIDA Notes Vol 16 #2, 2001
15 EtOH Dependence In homeostasis, inhibition and excitation centers are balanced (GABA vs. Glu) EtOH tips the balance to bottom out inhibition (GABA) When a person develops tolerance, EtOH and adaptation mechanisms tend to balance each other During acute withdrawal, the adaptation mechanism (excitation center Glu) bottoms out In post acute withdrawal (which can last a year or more) the excitation centers remain tipped which can lead to extended symptoms like sleep/mood disturbances EtOH increases dopamine levels in the reward pathway
16 And then there s methamphetamine Hypersexuality Sex marathons Prolonged arousal and long periods of sexual activity cause degradation of genital mucosa
17 Ecstasy (MDMA)
18
19
20 Ecstasy/MDMA X Methylenedioxymethamphetamine Early 19 th century Merck (1891) Blocks serotonin reuptake and actually induces neurons to pump serotonin into synapses Also blockades norepinephrine and dopamine Hugginess probably due to release of oxytocin
21
22 SUD and OCD Both groups have diminished dopaminergic activity in frontal lobe areas This may explain the obsessiveness of addiction and why addicts often have intrusive and obsessional drug-related thoughts that resist their control 1 1. Nora Volkow, McMillan 2003
23 Abuse vs. Dependence Continue use despite problems Tolerance Physical withdrawal
24 Mesolimbic Dopamine System Medial Forebrain Bundle Extended amygdala Central nucleus of amygdala Nucleus of the stria terminalis Transition zone (medial shell) of NAcc
25 Medial Forebrain Bundle Structures ventral tegmental area (VTA) lateral hypothalamus (LH) nucleus accumbens (NAcc) frontal cortex (FC) prefrontal cortex (pfc) orbitofrontal cortex (ofc)
26 Addiction Centers
27 Dependence Neurotransmitters Dopamine (DA) Serotononin (SER) Endorphins (END) Gamma-aminobutyric acid (GABA) Glutamate (Glu) - phencyclidine and Ketamine are Glu the NMDA receptor - GABA precursor Acetylcholine (Ach) Enkephalins (opioid pentapeptides; products of proenkephalin geneend in leucine or methionine) Norepinephrine NMDA (N-Methyl D-Aspartate) Activation of NMDA receptors results in the opening of a cation nonselective ion channel. (Na+ and small amounts of Ca2+ ions in and K+ out of the cell). Mimics Glu Cannabinoids Neuropeptide Y (most abundant, specific here to anxiety response, leptin blocks)
28 Meds. & how they work Acamprosate (Campral) modulates Glu and helps restore GABA/Glu stasis, therefore minimizing LT adverse effects and making abstinence more comfortable Naltrexone (ReVia, Vivitrol) blocks opioid receptors and diminishes some of the + effects of EtOH (May be most effective for heavy drinkers with + family Hx of addiction and pts. compliant w/ Tx) Must be opioid free at initiation and carry ID card Disulfuram (Antabuse) EtOH metabolism antagonist, producing averse effects (severe headache, severe vomiting, diaphoresis, chest pain/palpitations) (May be most effective for pts. with episodic vulnerability to relapse (holidays, etc.) n.b. Any EtOH can trigger reaction (even topicals) Buprenorphine and buprenorphine+naloxone (Suboxone) Used for opioid maintenance Less abuse potential than methadone. Can get 30 day supply so not tied to dispensing center Methadone still Tx of choice for pregnant females
29 Investigational Tx s Modafinil (Provigil) for stimulant dependence Baclofen (Lioresal) for cocaine dependence Topiramate (Topamax) for EtOH and cocaine dependence Cocaine vaccine failed
30 Nicotine Dependence Replacement therapies Bupropion (Zyban) Verenicline (Chantix)
31 Co-occurring Disorders Individuals are said to have COD if they have a Psychiatric Disorder as well as a Substance Use Disorder (SUD) It can be difficult to establish which came first. Why?
32 Where do You Start? Both disorders must be treated, however it may be more efficacious to treat one before the other Providers must be aware of the complexities of treating co-occurring disorders and MUST rely on their MH or Addictions Tx counterparts to effectively treat (Like MH providers, Addictions Tx providers must carry certification (state at minimum) Acknowledgement of patient s rights and belief in his/her ability to change Cultural competency a must-examples?
33 No Wrong Door No Wrong Door philosophy is vital. What does this mean, not just for our patients but for us as providers? (Willingness to work with COD, awareness of resources, awareness of scope of practice ASAM requires majority of SUD Tx providers be crosstrained)
34 Commonly Seen Psychiatric Disorders in PLWHIV (Persons Living with HIV/AIDS) Mood Disorders Depression is most common (clinical or situational?) Adjustment Disorders Anxiety Disorders SUD
35 Suicidality Assessment Suicide plans, means and intent Delusions and command hallucinations Impulsivity or impaired judgment of cognition History of suicidal or homicidal behavior
36 Developing Tx Plans for Patients with Significant COD Concentrate on setting limits why? Consider the use of behavioral contracts Make all staff aware of the contract why? Use a healthcare network/team to provide care Focus on long term goals, not immediate rewards Educate staff! Sellers, M. 2010
37 Consider Possibility of PTSD (Not just HIV but also SUD) Alterations in affect regulation (blocking) Alterations in consciousness (numbing) Alterations in self-perception (dirty) Alterations in relations with others (isolation) Alterations in systems of meaning (church) Proposed in DSM V Alterations in perception of perpetrator
38 Stages of Change 1. Precontemplation (no awareness of a problem) 2. Contemplation: Awareness of a problem, may seek information but no readiness to commit to change (ambivalent) 3. Preparation: Decided and committed to change but not yet working on the problem 4. Action: Actively initiating changes in themselves and/or environment 5. Maintenance: Changes made but difficulty in maintaining them may occur Source: Prochaska & DiClemente 1982, 1983
39 Motivational Interviewing A directive, patient-centered milieu for eliciting behavior change by helping patients explore and resolve ambivalence Begins with the supposition that patients come to the process with a basic capacity for actualization of a positive self and are responsible for creating change Provider s role: create conditions shown to enhance likelihood that a patient will engage in efforts to change behavior Source: Rollnick & Miller, 1995
40 The 4 Parts of Motivational Interviewing 1. Express empathy - reflective listening clarifies and enhances the patient s thinking, helps build a working alliance and supports patient s exploration of his/her ambivalence about change (1) Empathetic provider style has been shown to be a predictor of decreased patient resistance (2) Source: 1. Miller and Rollnick, 1991; 2. Miller et al, 1993
41 What Empathy Is According to Miller and Rollnick, 1991, empathy is a specifiable and learnable skill for understanding another s meaning through the use of reflective listening, i.e. letting them know you re on the same page by reflecting back what they ve said Communicates respect for and acceptance of patients and their feelings Encourages a nonjudgmental, collaborative relationship Allows you to be supportive Listens rather than tells Sincerely complements rather than put down Gently persuades, keeping the understanding that the decisions about change are the patient s Is NOT identifying with the patient Accepts that ambivalence is normal Example: I don t know why my wife is making such a big deal about this. I don t have a drinking problem -Your wife has some issues with how much you drink
42 What Empathy is Not Ordering, directing or even giving advice (if I were you, I would think about or maybe you should think about) Trying to persuade with logic, arguing or lecturing Warning or threatening Moralizing, preaching or telling patients their duty Judging, criticizing or blaming Agreeing, approving or praising inappropriately-these can shut down further communication Shaming, labeling Interpreting, analyzing, supplying answers Reassuring, sympathizing or consoling Questioning or probing Withdrawing, or using humor to distract
43 The 4 Parts of Motivational Interviewing (con t) 2. Develop discrepancy (1) Develop awareness of discrepancy between where patient is and where he/she wants to be (2) Source: Miller and Rollnick, 1991
44 The 4 Parts of Motivational Interviewing (con t) 3. Roll with resistance (1) Just as empathetic style as been shown to reduce resistance, confrontational style has been shown to not only increase likelihood of resistance but also to be predictive of increased drinking at the end of a 12 month follow up (2) Source: 1. Miller and Rollnick, 1991; 2. Miller et al, 1993
45 The 4 Parts of Motivational Interviewing (con t) 4. Support self-efficacy (1) Remember that the patient is responsible for choosing and implementing change Develop awareness of supports Talking about how they would go about changing and what it might look like makes patients more likely to view those changes as realistic options (2) Source: 1. Miller and Rollnick, 1991; 2. Miller et al, 1993
46 Creative Sociopathy We re often forced to sell SA or MH on accepting a given patient, as they often refuse to see him/her b/c of poor assessment of the primary problem Vital to develop No wrong door LRADAC s Solution
47 ASAM Criteria (PPC-2R) 6 Assessment Dimensions + Levels of Care address degree of direct medical management, degree of structure, safety and security and degree of treatment intensity involved and act as a continuum, making it possible to track progress, setbacks and appropriateness of care across the broad timeline of Tx, recovery and relapse Intensity Rating Scale At least 7 studies (NIH-NIDA + SAMHSA-CSAT) indicating that adherence to ASAM criteria is associated with enhanced Tx retention Source: American Society of Addiction Medicine 2001
48 Essential Elements of Programs Meeting ASAM Criteria MD and PhD level staff skilled in Dx and referral A majority of staff are cross-trained to deal with SA and MH disorders Psychoeducational components of Tx address both SA and MH disorders A psychiatrist is available on site in acute settings and through coordination in all other settings Medication management is integrated into the Tx plan Counselors and nursing staff are trained to monitor and promote compliance with pharmacotherapies In programs that work with severely mentally ill persons, intensive CM and assertive community Tx services are available
49 Levels of Care Add -D (Variable Intensity Detox) to Levels I-IV if needed) Level 0.5: Early Intervention OMT: Opioid Maintenance Therapy Level I: Outpatient Tx Level II (II.1-II.5): Intensive Outpatient/Partial Hospitalization Level III (III.1-III.7): Residential/Inpatient Tx Level IV: Medically Managed Intensive Inpatient Tx Source: American Society of Addiction Medicine 2001
50 The Six Dimensions 1.) Intoxication/Withdrawal Historical: Detox and discharge Current: Link Detox to other addiction and biopsychosocial services. Detox is NOT Tx. Source: David Mee-Lee, MD 2001 and American Society of Addiction Medicine 2001
51 The Six Dimensions Con t. 2.) Biomedical Conditions/Complications Historical: Tx for complications of addiction only Current: Biomedical care integrated into Tx plan; increase knowledge and understanding of primary care and interventions Source: David Mee-Lee, MD 2001 and American Society of Addiction Medicine 2001
52 The Six Dimensions Con t. 3.) Emotional/Behavioral/Cognitive Historical: Tx complications and/or underlying y conflicts only Current: Treat any co-occurring problems and integrate with mental health needs Source: David Mee-Lee, MD 2001 and American Society of Addiction Medicine 2001
53 The Six Dimensions Con t. 4.) Readiness to Change Historical: If not ready for recovery, send away, ignore or nag Current: Motivational strategies and engagement; stages of change Source: David Mee-Lee, MD 2001 and American Society of Addiction Medicine 2001
54 The Six Dimensions Con t. 5.) Relapse/Continued Use Potential Historical: Ignore or reject from Tx Relapse is learning opportunity in a chronic illness of which relapse is a normal part; prevent drop-out and keep patient in care Source: David Mee-Lee, MD 2001 and American Society of Addiction Medicine 2001
55 The Six Dimensions Con t. 6.) Recovery Environment Historical: Little or no family or significant other integrated care; programmatic involvement only Current: In-depth assessment, wraps, individualized family care management or IFS Source: David Mee-Lee, MD 2001 and American Society of Addiction Medicine 2001
56 Considerations When Referring HIV+ Patients into Tx Programs Access to medical care & follow up How will their medications be supplied? If referring PLWHIV out of state, what is that state s ADAP status? Do they have a wait list? Possibility of continuing to receive ART from SC ADAP Possible loss of Medicaid
57 Predictors of Response to Psychotherapy Socioeconomic Status: + correlation between higher social class and retention in therapy + Correlation between years of education and length of stay in Tx Race: In a study of 17 community mental health centers ethnic minority clients attended significantly fewer sessions than Caucasian clients;(1); Other studies show no correlation (2) Gender: Although women seek Tx more often, there is no significant difference in dropout rates Source: 1.) Greenspan & Kulish, 1985; 2.) Sledge 1990
58 Predictors of Response to Psychotherapy (con t.) Age: Some studies suggest a relationship between age and retention (1); most suggest no correlation (2) Marital Status: For general psychotherapy, no significant correlation, however for substance abuse therapy + correlation between being married and retention patients who rate their marriages unsatisfactory before Tx fare much worse during and following Tx than those who rated their relationships better (3) Intelligence: Lit. reviews indicate + relationship between higher intelligence and enhanced outcomes. Source: 1.) Greenspan & Kulish (1985); 2.) Sledge et al (1990); 3.) Milton & Hafner (1979); 4.) Luborsky, Singer & Luborsky (1975)
59 Compliance: It s not Just an AOD Problem 60% of those in AOD Tx drop out in the first month <60% of adult Dx d hypertensives are Tx adherent <50% of patients with DM are Tx adherent <30% of both groups modify their diet/lifestyles as recommended 50% of all amputations and adult onset blindness in US are result of failure to adhere to DM Tx Source: Minkoff, 2003
60 Relapse Relapse IS NOT treatment failure-it is a learning opportunity Relapse is not an isolated event; it is a process, often taking several weeks, that ultimately leads to the addict returning to AOD use Seemingly unrelated situations, such as being dishonest about issues not related to AOD use, legal violations and worrying about others are often precursors to relapse 1 st 90 days-85% relapse rate; 6 months-1 year - 60% relapse rate; 1-3 years 33% relapse rate; 5 years and after 15%
61 Gorski s Developmental Model of Recovery 1.) Transition: Recognizes problems but tries to surmount them by controlling substance use 2.) Stabilization: Individual decides to refrain from substance use completely and improves over an extended period of time (6-18 mos.) 3.) Early recovery: Individual becomes comfortable with abstinence Source: Gorski, 1989
62 Gorski s Developmental Model of Recovery 4.) Middle Recovery: Individual repairs past damages caused to others by AOD use and develops balanced lifestyle 5.) Late Recovery: Individual overcomes barriers to healthy life that stem from childhood experiences 6.) Maintenance: Individual recognizes need for continued growth and balanced life Source: Gorski, 1989
63 Marlatt s Recovery Model Individual should be able to identify and even anticipate high risk situations Individual must possess the skills needed to effectively cope with those situations Individual should have expectation that using these skills will result in a positive outcome Source: Marlatt, 1993
64 Marlatt s Recovery Model Relapse Management 1 (End relapse quickly and minimize damage it causes) Consider relapse an unfortunate but isolated incident, not that individual is incapable of recovery Source: 1. Curry & McBride, 1994
65 Additional Resources
66 OK, So what do they want from us? We as providers can play a role in our patient s recovery, helping them in their process of developing a positive identity as a recovering substance abuser.
THE STATE OF MEDICINE IN ADDICTION RECOVERY
OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,
More informationMotivating Behavior Change What Really Works? Pre-Test
Motivating Behavior Change What Really Works? Practice of Medicine I Christine M. Peterson, M.D. Terry Saunders, Ph.D. Pre-Test Among deaths in the U.S. that occur prematurely, the per cent attributable
More informationMotivational Enhancement Therapy & Stages of Change
Motivational Enhancement Therapy & Stages of Change Learning Objectives Participants will be able to: 1) Identify the stages of change and how they can be implemented 2) Describe the principles of MET
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationBASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment Module 2 Motivating clients for treatment and addressing resistance Basic counselling skills for drug dependence treatment Special considerations when
More informationReferral to Treatment: Utilizing the ASAM Criteria
Referral to Treatment: Utilizing the ASAM Criteria AOAAM Essentials in Addiction Medicine October 22, 2016 East Lansing, MI Stephen A. Wyatt, DO Medical Director, Addiction Medicine Behavioral Health Service
More informationThe New ASAM Criteria: Implications for Drug Courts
The New ASAM Criteria: Implications for Drug Courts NADCP 21 st Annual Training Conference July 29, 2015 Washington, DC David Mee-Lee, M.D. Chief Editor, The ASAM Criteria Senior Vice President The Change
More information8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy
Medication Assisted Treatment for Substance Abuse in Primary Care Dan Vinson August 1, 2013 1 The Big change in addiction medicine? These diseases are rapidly becoming medical diseases. Done are the days
More informationUnderstanding the Brain: What Drugs Can Tell Us
LIVE INTERACTIVE LEARNING @ YOUR DESKTOP Understanding the Brain: What Drugs Can Tell Us Presented by: Dr. Rochelle D. Schwartz-Bloom March 24, 2011 Understanding the Brain: What Drugs Can Tell Us Rochelle
More informationMotivating Behavior Change What Really Works?
Motivating Behavior Change What Really Works? Pre-Test Practice of Medicine 1 Christine M. Peterson, M.D. David Waters, Ph.D. Do You Know? Half of all deaths in the US are attributable to personal behavior,
More informationTOOL 1: QUESTIONS BY ASAM DIMENSIONS
TOOL 1: QUESTIONS BY ASAM DIMENSIONS The following tool highlights specific questions that should be asked of the patient for each ASAM dimension. Name Date of Birth Date of Interview Address Referred
More information*IN10 BIOPSYCHOSOCIAL ASSESSMENT*
BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding
More informationNational Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says
National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationHow Addiction Affects the Brain: The Neuroscience of Compulsive Behavior
How Addiction Affects the Brain: The Neuroscience of Compulsive Behavior Table of Contents INTRODUCTION.... 3 NEUROSCIENCE 101: NEURONS AND NEUROTRANSMITTERS.... 4 BRAIN REGIONS INVOLVED IN ADDICTION:
More informationPsychoactive drugs Drugs which affect mental processes. Legal but restricted (by prescription only)
Psychoactive drugs Drugs which affect mental processes mood, perception, memory, state of consciousness May be illegal: Heroin Cocaine Legal: Alcohol nicotine Legal but restricted (by prescription only)
More informationMotivating Behavior Change What Really Works?
Motivating Behavior Change What Really Works? Practice of Medicine Christine M. Peterson, M.D. Pre-Test Do You Know? Half of all deaths in the US are attributable to personal behavior, including: Tobacco
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
More informationCouncil on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain
Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction
More informationMotivational Interviewing
Motivational Interviewing By: Tonia Stott, PhD What is Motivational Interviewing? A client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence
More informationThe Biological Perspective. Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo
The Biological Perspective Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo The Biological Perspective What is it? More than «the» one biological
More informationAdolescents And Addiction
Adolescents And Addiction 1) According to the Substance Abuse and Mental Health Services Administration (SAHMSA), over million people over the age of 12 years needed treatment for substance use in 2012.
More informationIdentify the benefits of using a Brief Negotiated Intervention (BNI) to screen for alcohol and drug disorders. Review a four step model of Screening,
Kate Speck, PhD Identify the benefits of using a Brief Negotiated Intervention (BNI) to screen for alcohol and drug disorders. Review a four step model of Screening, Brief Intervention and Referral to
More informationAt a Glance. Background Information. Lesson 3 Drugs Change the Way Neurons Communicate
Lesson 3 Drugs Change the Way Neurons Communicate Overview Students build upon their understanding of neurotransmission by learning how different drugs of abuse disrupt communication between neurons. Students
More informationTrigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module VI Counseling Buprenorphine Patients Myths About the Use of Medication in Recovery! Patients are still addicted!
More informationWhat is Treatment Planning? Clinical Evaluation: Treatment Planning Goals and Objectives
Clinical Evaluation: Treatment Planning Goals and Objectives 1) Define Treatment Planning 2) Understanding of Correlation Between Assessment and Treatment Planning 3) Overview of Treatment Planning Process
More informationThe science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
More informationMOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre
1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement
More informationMotivational Interviewing Maureen P. Scahill, NP, MS Center for Health & Behavioral Training
Motivational Interviewing Maureen P. Scahill, NP, MS Center for Health & Behavioral Training Infectious Disease Division, Department of Medicine, University of Rochester Medical Center STD/HIV Program,
More informationWhat Using The ASAM Criteria Really Means: Skill-Building and Systems Change. David Mee-Lee, M.D.
What Using The ASAM Criteria Really Means: Skill-Building and Systems Change David Mee-Lee, M.D. Chief Editor, The ASAM Criteria Senior Vice President The Change Companies Carson City, NV Davis, CA davidmeelee@gmail.com
More informationNeuroscience of Addiction
Neuroscience of Addiction Carlton Erickson, Ph.D. Associate Dean for Research and Graduate Studies Distinguished Professor of Pharmacology Director, Addiction Science Research and Education Center College
More informationUnderstanding Addiction: Why Can t Those Affected Just Say No?
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
More informationAdolescents And Addiction
Adolescents And Addiction 1) According to the Substance Abuse and Mental Health Services Administration (SAHMSA), over million people over the age of 12 years needed treatment for substance use in 2012.
More informationAODA RECOVERY. How to support those in recovery, and those not yet ready to commit
AODA RECOVERY How to support those in recovery, and those not yet ready to commit YOUR PRESENTER TODAY Robin Lickel is a psychotherapist and addictions specialist at Journey Mental Health Center in Madison,
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners Grand Rounds October 11, 2017 Disclosures One
More informationMotivational Interactions
Motivational Interactions James Carter, Ph.D. Specialty Behavioral Health UCSD Dept. of Psychiatry Presented for TRICOR Nashville, TN June 9, 2011 What motivates people to change? Rewards Punishments /
More informationIntroduction to Motivational Interviewing in NAS Interventions
Introduction to Motivational Interviewing in NAS Interventions Daniel Raymond Tanagra M. Melgarejo Workshop Overview 1 Training Objectives By the end of this session you will be able to: Describe the fundamental
More informationDSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW
DSM-5 AND ASAM CRITERIA Presented by Jaime Goffin, LCSW MODULE 1: GOALS & OBJECTIVES What is your experience with using ASAM and DSM 5 criteria? What are your learning expectations for today? GOAL FOR
More informationTreatment of Substance Use Disorders in the Real World. Jessica M. Peirce, Ph.D. Johns Hopkins University School of Medicine
Treatment of Substance Use Disorders in the Real World Jessica M. Peirce, Ph.D. Johns Hopkins University School of Medicine Objectives identify the core components of the most common substance use disorder
More informationSubstance Abuse Level of Care Criteria
Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:
More informationClasses of Neurotransmitters. Neurotransmitters
1 Drugs Outline 2 Neurotransmitters Agonists and Antagonists Cocaine & other dopamine agonists Alcohol & its effects / Marijuana & its effects Synthetic & Designer Drugs: Ecstasy 1 Classes of Neurotransmitters
More informationWhat Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016
What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)
More informationPossession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no
Dr. Joseph Garbely Medical Director VP of Medical Services Caron Treatment Centers 1 ASAM Disclosure of Relevant Financial Relationships No Relevant Financial Relationships with Any Commercial Interests
More informationDiscover the Hope: Opiate Treatment and Recovery
Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of
More informationConceptual Models of Substance Use
Conceptual Models of Substance Use Different causal factors emphasized Different interventions based on conceptual models 1 Developing a Conceptual Model What is the nature of the disorder? Why causes
More informationIDDT Fidelity Action Planning Guidelines
1a. Multidisciplinary Team IDDT Fidelity Action Planning Guidelines Definition: All clients targeted for IDDT receive care from a multidisciplinary team. A multi-disciplinary team consists of, in addition
More informationBRAIN MECHANISMS OF REWARD AND ADDICTION
BRAIN MECHANISMS OF REWARD AND ADDICTION TREVOR.W. ROBBINS Department of Experimental Psychology, University of Cambridge Many drugs of abuse, including stimulants such as amphetamine and cocaine, opiates
More informationIs there any way you might be better off if you quit? What happens when you think about it? What do you imagine will happen if you don t change?
This material has been prepared by the Massachusetts Smoker's Quitline, a program of the American Cancer Society. STAGES OF CHANGE Research on addiction and behavior change done by Prochaska and DiClemente,
More informationUnderstanding and Using Current ASAM Criteria. for Ce-Classes.com
Understanding and Using Current ASAM Criteria for Ce-Classes.com Learning Objectives After completing this course, participants will: Identify ASAM and the history of its development Describe how ASAM
More informationSTAGE OF CHANGE & TX PLANNING-11/19 1
1 PROCHASKA AND DICLEMENTE: STAGE of CHANGE MODEL 2 3 STAGE OF CHANGE & TX PLANNING-11/19 1 Is there anything about your alcohol or drug use you would like to change? Pre-contemplation I don t have a problem
More informationAddiction Medicine: What s new for primary care
Addiction Medicine: What s new for primary care Dan Vinson, MD Family and Community Medicine How to talk so our patients listen, and listen so our patients talk. 1 2 Comfortably engaging your patient in
More informationDr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.
David W. Oslin, MD University of Pennsylvania Philadelphia VAMC Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. Dr. Oslin is a consultant to the Hazelden Betty
More informationNIDA Quick Screen V1.0F1
NIDA Quick Screen V1.0F1 Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to ask you a few
More information7/7/2016 Journal of the American Medical Association,
1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of
More informationTreatment Team Approaches in Substance Abuse Treatment
Treatment Team Approaches in Substance Abuse Treatment PLANT A SEED AND WATCH IT GROW 2 Substance use disorders span a wide variety of problems arising from substance use, and cover 11 different criteria:
More informationSubstance Use Disorders in Primary Care
Substance Use Disorders in Primary Care Jin Hee Yoon-Hudman, MD Assistant Vice President, Medical Director, Behavioral Health Healthfirst Fall Symposium Prevention as a Priority in Value-Based Healthcare,
More informationDrugs, addiction, and the brain
Drugs, addiction, and the brain Topics to cover: What is addiction? How is addiction studied in the lab? The neuroscience of addiction. Caffeine Cocaine Marijuana (THC) What are the properties of addiction?
More informationTreatment and the Recovery Process. Treatment Options. Treatment Options. Hagedorn MHS
Treatment and the Recovery Process W. Bryce Hagedorn, PhD, LMHC, NCC, MAC Treatment Options Settings Inpatient Hospitalization Short term ( days) used for detox, stabilization, & safety Inpatient Residential
More information11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no
Dean Drosnes, MD, FASAM Associate Medical Director Caron Treatment Centers ASAM Disclosure of Relevant Financial Relationships Date of Activity: Nov 3, 2016 Name Commercial Interests Relevant Financial
More informationUMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING
UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING Course Description Goals and Learning Objectives 55 Lake Ave North, Worcester, MA 01655 www.umassmed.edu/tobacco 1 Table of Contents Determinants of Nicotine
More informationMotivational Interviewing for Family Planning Providers. Motivational Interviewing. Disclosure
for Family Planning Providers Developed By: Disclosure I I have no real or perceived vested interests that relate to this presentation nor do I have any relationships with pharmaceutical companies, biomedical
More informationUnderstanding Addiction. Understanding Addiction. Acknowledgements. KP Regional Pain Symposium August 8, Mary Eno MD, MPH
Understanding Addiction KP Regional Pain Symposium August 8, 2011 Mary Eno MD, MPH Chief of Addiction Medicine SCPMG South Bay Understanding Addiction Why addicted patients baffle and overwhelm us Limbic
More informationMotivational Interviewing in Chronic Diseases. Janelle W. Coughlin, Ph.D. Megan Lavery, Psy.D.. April 21, 2017
Motivational Interviewing in Chronic Diseases Janelle W. Coughlin, Ph.D. Megan Lavery, Psy.D.. April 21, 2017 Motivational Interviewing in Chronic Diseases Presenter Names: Janelle W. Coughlin, Ph.D. &
More informationVOLUME B. Elements of Psychological Treatment
VOLUME B Elements of Psychological Treatment VOLUME B MODULE 1 Drug dependence and basic counselling skills Biology of drug dependence Principles of drug dependence treatment Basic counselling skills for
More informationAmerica is a drugged society
Overview of Drug Abuse Basic Considerations. M. Imad Damaj, Ph.D. Associate Professor Dept. of Pharmacology/Toxicology, Virginia Commonwealth University America is a drugged society 90% of all drugs manufactured
More informationTony Klein, MPA, CASAC, NCACII
Tony Klein, MPA, CASAC, NCACII Presentation Overview Tobacco Dependence in Individuals with Co-occurring Addictions Challenges and Barriers Organizational Change Strategies Program & System Changes to
More informationWelcome to Motivational Interviewing Enhancing Motivation to Change Strategies. This is the third module that you ll be taking about motivational
Welcome to Motivational Interviewing Enhancing Motivation to Change Strategies. This is the third module that you ll be taking about motivational interviewing. 1 The goals for this session are listed on
More informationMedication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.
Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation
More informationMedical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center
Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers
More informationMedication-Assisted Treatment. What Is It and Why Do We Use It?
Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite
More informationAnyone Can Become Addicted. Anyone.
Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.
More informationCO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS
INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS 2009 MARRCH CONFERENCE 22 October 2009 CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS 1. Common in the
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationPROCHASKA AND DICLEMENTE: STAGE of CHANGE MODEL. Prochaska and DiClemente s Stage of Change Model 2
1 PROCHASKA AND DICLEMENTE: STAGE of CHANGE MODEL Prochaska and DiClemente s Stage of Change Model 2 3 1 Is there anything about your alcohol or drug use you would like to change? Pre-contemplation No
More informationMOTIVATIONAL INTERVIEWING
MOTIVATIONAL INTERVIEWING Facilitating Behaviour Change Dr Kate Hall MCCLP MAPS Senior Lecturer in Addiction and Mental Health School of Psychology, Faculty of Health, Deakin University. Lead, Treatment
More informationA MULTI-LAYERED APPROACH TO RECOVERY: VETERAN AND MILITARY FAMILY CASE EXAMPLES
A MULTI-LAYERED APPROACH TO RECOVERY: VETERAN AND MILITARY FAMILY CASE EXAMPLES Heather Kapson, PhD Ann Stewart, LICSW September 18, 2017 DISCLOSURES None HOME BASE PROGRAM Red Sox Foundation and Massachusetts
More informationThe future of pharmacological treatment.
The future of pharmacological treatment. Anne Lingford-Hughes Professor of Addiction Biology, Imperial College. Hon Consultant CNWL NHS Foundation Trust. What substances and when? What Nicotine Alcohol
More information9/17/15. Patrick Boyle, mssa, lisw-s, licdc-cs director, implementation services Center for Evidence-Based Case Western Reserve University
Patrick Boyle, mssa, lisw-s, licdc-cs director, implementation services Center for Evidence-Based Practices @ Case Western Reserve University 1 What changes are residents you serve considering? What changes
More informationEffective Treatment: Doing the Right Thing, In the Right Way. Terrence D Walton, MSW, ICADC
Effective Treatment: Doing the Right Thing, In the Right Way Terrence D Walton, MSW, ICADC Monitor Manage Impact 1. Understand the Treatment Field, including Evidenced Based Practices 2. Understand Your
More informationChapter 7. Screening and Assessment
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
More informationTreating Tobacco Use and Dependence
Treating Tobacco Use and Dependence October 26, 2017 Great Plains Quality Improvement Network 1 Treating Tobacco Use and Dependence: Agenda Brief history and developmental process Facts about Tobacco Clinical
More informationMotivational Interviewing
Motivational Interviewing Barbara M. Miller, RN, CEC Robin Seabury, MS WVU School of Nursing And Finally What Do You Want To Leave With Today? Change Remember, change is much larger than behavior.
More informationNIDA-Modified ASSIST Prescreen V1.0 1
NIDA-Modified ASSIST Prescreen V1.0 1 F Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to
More informationASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service
1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 0 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 1 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 2 The patient
More informationMATCP When the Severity of Symptoms Interferes with Progress
MATCP 2017 When the Severity of Symptoms Interferes with Progress 1 Overview Stages of Change, or Readiness for Change Changing Behavior Medication Adherence Disruptive Behaviors Level of Care Tools including
More informationManagement of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur
Management of Tobacco Dependence Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur Difficult to identify any other condition that presents such a mix of lethality, prevalence,
More informationOpioid Overdose Epidemic A Crises and Opportunity
Opioid Overdose Epidemic A Crises and Opportunity Samuel M. Silverman MD, FAPA, DFASAM Assistant Clinical Professor, UConn Medical School Director, Medical Education Rushford, A Hartford HealthCare Partner
More informationTHE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.
THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.
More informationCell body, axon, dendrite, synapse
SOME BASIC NEUROSCIENCE Neurons have specialised extensions 1: Label the parts of a neuron by selecting the correct term from the box below. Cell body, axon, dendrite, synapse 1 dendrite synapse cell body
More informationPsychotropic Drugs Critical Thinking - KEY
Open Your Class with This Tomorrow Chasing the Scream: The First and Last Days of the War on s Psychotropic s Critical Thinking - KEY Background: The blood-brain barrier is a network of tightly packed
More informationTreatment Alternatives for Substance Use Disorders
Treatment Alternatives for Substance Use Disorders Dean Drosnes, MD, FASAM Associate Medical Director Director, Chronic Pain and SUD Program Caron Treatment Centers 1 Disclosure The speaker has no conflict
More informationGOALS AND OBJECTIVES
SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES
More informationTopics of today s training
Extended Release Naltrexone Vivitrol Christopher J Davis D.O. CAADC, FASAM Medical Director, Brightwater Landing Medical Director, Pyramid Healthcare Diplomate of The American Board of Addition Medicine
More informationBENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU
BENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU TABLE OF CONTENTS 4 Benzodiazepine Addiction 8 Xanax Withdrawal Symptoms 11 Professional Help for Benzo Withdrawal is Essential for Success 15 Relapse
More informationWhat is addiction and what can businesses do about it?
What is addiction and what can businesses do about it? Michael M. Miller, MD, DFASAM, DLFAPA Director of Addition Program Development and Training Rogers Behavioral Health Business Health Care Group April
More informationChild Welfare and Substance Abuse. Erica Tarasovitch, MSW Central Florida Behavioral Health Network
Child Welfare and Substance Abuse Erica Tarasovitch, MSW Central Florida Behavioral Health Network Parental Substance Use Marijuana was the most commonly used illicit drug in 2006, accounting for 72.8
More informationEffectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018
Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use Chad Morris, PhD March 7, 2018 2018 BHWP Behavioral Causes of Death in U.S. 2018 BHWP 2018 BHWP Health Disparities Population Behavioral
More informationUsing Screening, Brief Intervention & Referral to Treatment (SBIRT) in Practice: A Skills Building Workshop
Using Screening, Brief Intervention & Referral to Treatment (SBIRT) in Practice: A Skills Building Workshop Joanne DeSanto Iennaco PhD, PMHNP BC, PMHCNS BC, APRN Acknowledgements Yale SBIRT Medical Health
More informationMotivational Interviewing. Calvin Miller, CADC, MAATP
Motivational Interviewing Calvin Miller, CADC, MAATP Why use Motivational Interviewing? Respectful approach Considers the where the client is at in the Stages of Change. Considers the client s resources.
More informationPharmacotherapy for Substance Use Disorders
Pharmacotherapy for Substance Use Disorders Vanessa de la Cruz, MD Chief of Psychiatry Mental Health and Substance Abuse Services Santa Cruz County Health Services Agency 1400 Emeline Avenue Santa Cruz,
More information